MIRA INFORM REPORT

 

 

Report Date :

02.04.2008

 

 

IDENTIFICATION DETAILS

 

Name :

OCTIS RESEARCH LABORATORIES PRIVATE LIMITED

 

 

Registered Office :

14/7, Malar Apartments, 2nd West Main Road, Shenoy Nagar, Chennai – 600030, Tamilnadu

 

 

Country :

India

 

 

Date of Incorporation :

05.04.2006

 

 

Com. Reg. No.:

59437

 

 

CIN No.:

[Company Identification No.]

U01117TN2006PTC059437

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

CHEO03606B

 

 

PAN No.:

[Permanent Account No.]

AAACO8233A

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing of all sorts of tablets and hard gelatin capsule

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

New Company

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is a relatively new company and has not published its first financials till date. The company has been successful in obtaining good amount of loans from its bankers. Trade relations are fair. Payments are reported as slow but correct.

 

 

The company can be considered for small to mediocre business dealings, with slight caution, initially. 

 

 

LOCATIONS

 

Registered Office :

14/7, Malar Apartments, 2nd West Main Road, Shenoy Nagar, Chennai – 600030, Tamilnadu, India

E-Mail :

enquiries@octis.in  ; octis_vjt@yahoo.co.in ; nostrumravi@yahoo.co.in

Website :

http://www.octis.in

 

 

Head Office :

72, N – Block, 153/24, Lotus Colony, Anna Nagar [West], Chennai – 600102, Tamilnadu, India

 

 

Corporate Office :

IHFD Abodes, 4/1 Third Main Road, Shenoy Nagar [West], Chennai – 600030, Tamilnadu, India

Tel. No.:

91-44 – 2621 4462

Fax No.:

91-44 - 4203 2676

 

 

Factory :

Located at : Selaqui – Dehradun

 

 

DIRECTORS

 

Name :

Mr. B. Balachandar

Designation :

Chairman

 

 

Name :

Mr. R. Ravichandran

Designation :

Managing Director

Address :

14/7, Malar Apartments, 2nd West Main Road, Shenoy Nagar, Chennai – 600030, Tamilnadu, India

Date of Birth :

05.02.1968

 

 

Name :

Mr. V.T. Ananthanarayanan

Designation :

Works Director

 

 

Name :

Mr. S.K. Ganesh

Designation :

Executive Director

Address :

72, N Block, 153/24, Lotus Colony, Anna Nagar, Chennai – 600102, Tamilnadu, India

Date of Birth :

14.01.1969

 

 

Name :

Mr. Balaguru K

Designation :

Directors

 

 

Name :

Mr. Harikrishnan R

Designation :

Directors

 

 

Name :

Mr. Karthik Prabhu M

Designation :

Directors

 

 

Name :

Mr. Karuppiah A.L

Designation :

Directors

 

 

Name :

Mr. Thanigaivel R

Designation :

Directors

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

List of Allottees on 23.08.2006

 

Names of Shareholders

 

 

No. of Shares

R. Ravichandran

 

10000

Radhika Ravichandran

 

10000

V T Anantha Narayanan

 

10500

K. Balaguru

 

20000

S. S. Sriram

 

10000

B. Balachandar

 

20000

S. K. Ganesh

 

22000

P. Senthilkumar

 

30000

V. Murugesan

 

20000

R. Thanigaivel

 

20000

Ezhilarasi Thanigaivel

 

10000

O. S. Kumaran

 

10000

B. Venugopal

 

30000

R. Harikrishnan

 

27500

A. L. Karuppiah

 

20000

A. Velappan

 

20000

M. Saravanan

 

20000

P. L. Kannan

 

50000

M. Karthikprabu

 

50000

J. Rajasaravanan

 

10000

N. P. Suresh Babu

 

10000

T. Asaithambi

 

20000

S. Pazhaniappan

 

20000

S. Balaji

 

20000

M. Paramasivam

 

20000

M. Anbukkarasu

 

20000

R. Baskaran

 

20000

D. S. Shanjay

 

20000

S. Vasudevan

 

10000

Ravikandasamy

 

20000

Hemalatha Ravi

 

10000

D. Karthy

 

20000

Deepak Saha

 

10000

Latha Kumaran

 

10000

R. Sivakumar

 

10000

R. Rajasundaram Sivakumar

 

10000

S. Rajaram

 

10000

R. Ganesan

 

10000

A. Sathyamurthi

 

10000

K. Balakumar

 

10000

N. Balasubramanian

 

30000

G. Gowri

 

10000

Total

 

750000

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing of all sorts of tablets and hard gelatin capsule

 

 

GENERAL INFORMATION

 

Customers :

  • Nostrum Pharmaceuticals
  • New Dawn Pharmaceuticals
  • Bharat Biologicals
  • Pharma Remedies
  • Harrisons Pharmaceuticals
  • Genera Laboratories
  • Spartan Burg Drugs
  • Care and Cures Pharmaceyaa
  • Balint Pharmaceuticals

 

 

Bankers :

Axis Bank Limited, Trishul 3rd Floor, Opposite Samartheshwar Temple, Law Garden Ellisbridge, Ahmedabad – 380006, Gujarat, India

 

 

 

Banking Relations :

Satisfactory

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

750000

Equity Shares

Rs. 100/- each

Rs. 75.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

23500

Equity Shares

Rs. 100/- each

Rs. 2.350 Millions

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

Not Available

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Bankers Charges Report as per Registry

 

 

This form is for

Creation of charge

Corporate identity number of the company

U01117TN2006PTC059437

Name of the company

OCTIS RESEARCH LABORATORIES PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

14/7, Malar Apartments, 2nd West Main Road, Shenoy Nagar, Chennai – 600030, Tamilnadu, India

Type of charge

Movable Property

Particular of charge holder

Axis Bank Limited, Trishul 3rd Floor, Opposite Samartheshwar Temple, Law Garden Ellisbridge, Ahmedabad – 380006, Gujarat, India

dehradun.branchhead@axisbank.com

Nature of description of the instrument creating or modifying the charge

Cash Credit of Rs. 2.500 Millions for financing the working capital requirement of the unit against first charge on current and movable fixed assets and other security as guarantee cover under CGTSI scheme and personal guarantee of the promoters.

Date of instrument Creating the charge

14.08.2007

Amount secured by the charge

Rs. 2.500 Millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest

At Bank’s PLR presently at 15 % p.a. payable monthly

 

Terms of Repayment

On demand

 

Margin

Margin on Stocks 25 % and receivables upto 60 days will be eligible for drawing power calculations.

 

Extent and Operation of the charge

To the extent of outstanding amount plus other charges.

 

Others

Stock statements to be submitted quarterly

Any excess drawing or irregularity on account of nonpayment of interest / charge / instalment will attract penal interest of Rs. 2 % p.a.

Security charged to bank including stock, movable fixed assets etc. should be comprehensively insured with bank clause and policy document to be submitted to bank.

Short particulars of the property charged

First charge on current asset and movable fixed assets

 

 

 

AS PER WEBSITE

 

Location:

 

OCTIS factory is situated at Selaqui – Dehradun a lovely & scenic valley and the capital of Uttarakhand. It maintains a pleasant climate with standard temperature of 5 to 30 degrees.


The factory is closer to the “Pharma City” and is exclusively designed for pharmaceutical manufacturing.

Of course it is in the “Tax free zone” thus there is no Excise Duty & Sales Tax. The co-operation & support by the concerned government authorities are very good & congenial.

 

Steering Team:

 

It is a unique joint venture of people with seasoned experience & expertise in all the spheres of Pharmaceutical Industry. The team comprises of Entrepreneurs, Production Chemists, Quality Control Chemists, Production Coordinators, Teaching Faculties, Marketing Managers, Sales Executives, Administrative Officers, Plant Managers, etc.,

 

Profile

 

The company is managed by professionally qualified team.

 

MANAGEMENT

 

Chairman

 

Mr. B. Balachandar

 

A B. Pharm from Madurai Medical College has more than 3 decades of experience in Marketing & Management. He was the founder Director of Tristar Formulations Private Limited, & is the CEO of Universal Biomedics which imports & markets super specialty surgical devices & equipments in India & Sri Lanka. He is also Director of Pharma Guide which has guided sizable number of Pharma marketing companies. He has conducted many training & development programs and was a teaching faculty for SISI.

 

Managing Director

 

Mr. R. Ravichandran

 

A B. Pharm from Annamalai University has production exposure in various section of Pharmaceutical production. He has got overseas management experience. His practical expertise steers M/s Nostrum for which he is the sole proprietor. OCTIS is his brain child.

 

Works Director

 

Mr. V.T. Ananthanarayanan

 

A  B. Pharm from Annamalai University has a wide production experience in various section of Pharmaceutical production. He has volunteered to be in OCTIS for state of the art production. He is in the site & involves in the production activity.

 

Executive Director

 

Mr. S.K. Ganesh

 

A B. Pharm from Annamalai University has production exposure in various section of Pharmaceutical production. .He has got overseas management experience.  He has volunteered to be in OCTIS for administration. He is in the site & involves in Administrative activity.

 

Directors

Mr. Balaguru. K

 

Managing Director of “Ostics” & Pharma Remedies has a rich experience in the Pharma industry having good expertise in Sales, Administration & Human relations.

 

Mr. Harikrishnan. R

 

Managing partner of “Yamuna Roto Prints” has a rich experience of 23 years in the aluminium cap and foil business.

 

Mr. Karthik Prabhu. M

 

A B. Pharm from Ultra College of Pharmacy & MBA from Kamaraj University is MD of “Bharath Biologicals”, “Star Biotech”, & “Nectar Herbal Research Laboratories”. He has a rich experience in the Sales & Administration of Pharmaceutical Industry.

 

Mr. Karuppiah. A.L

 

A B.Com graduate with twenty-one years of pharmaceutical products marketing experience and M.D of “New Dawn Pharmaceuticals”

 

Mr. Thanigaivel R

 

A B. Pharm from Annamalai University is MD of “Genera laboratories”. He has rich experience in the Sales & Administration of Pharmaceutical industry.

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.39.97

UK Pound

1

Rs.79.53

Euro

1

Rs.63.09

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

2

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

27

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions